| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DBV Technologies S.A. | $17.70 | -2.9% | $1516.19T | -0.7 | 11.8% | — | Healthcare | 122.9% | -100% | ||
| 2 | Eli Lilly and Company | $1083.23 | 1.7% | $1.02T | 47.2 | 129% | 0.6% | Healthcare | 44.3% | 47.4% | ||
| 3 | Johnson & Johnson | $223.24 | 0.2% | $537.99B | 38.6 | 78.9% | 2.2% | Healthcare | 44.6% | 3.7% | ||
| 4 | AbbVie Inc. | $217.07 | 0.8% | $383.94B | 91.6 | -1.4% | 3% | Healthcare | 15.9% | 8.6% | ||
| 5 | UnitedHealth Group Incorporated | $377.00 | -0.2% | $342.19B | 28.5 | -44.6% | 2.3% | Healthcare | 25.2% | 9.7% | ||
| 6 | Merck & Co., Inc. | $114.80 | -0.8% | $283.54B | 15.8 | 8.2% | 2.8% | Healthcare | 48.8% | 1.2% | ||
| 7 | Novartis AG | $143.66 | 0.1% | $274.12B | 20.0 | 9.2% | 2.8% | Healthcare | 23.9% | 5.3% | ||
| 8 | AstraZeneca PLC | $176.28 | -0.7% | $273.28B | 27.0 | 33.1% | 1.8% | Healthcare | 23.7% | 9.9% | ||
| 9 | Novo Nordisk A/S | $42.00 | -2.1% | $186.64B | 11.7 | 16.8% | 4.3% | Healthcare | -40.8% | 8.1% | ||
| 10 | Amgen Inc. | $338.22 | 3% | $182.53B | 23.8 | 31.1% | 2.8% | Healthcare | 16.8% | 9.1% | ||
| 11 | Thermo Fisher Scientific Inc. | $473.95 | -1.7% | $176.13B | 26.7 | 6.7% | 0.4% | Healthcare | 18.5% | 5.4% | ||
| 12 | Gilead Sciences, Inc. | $128.99 | 1.1% | $160.15B | 19.0 | 54.5% | 2.5% | Healthcare | 18% | 3.5% | ||
| 13 | Abbott Laboratories | $87.02 | 0.1% | $151.32B | 11.4 | 142.5% | 2.5% | Healthcare | -34.9% | 6.4% | ||
| 14 | Intuitive Surgical, Inc. | $407.29 | 1.2% | $144.66B | 51.8 | 21% | — | Healthcare | -26.2% | 21.4% | ||
| 15 | Pfizer Inc. | $25.36 | -0.8% | $144.23B | 18.6 | -5.1% | 6.8% | Healthcare | 8.6% | 1.4% | ||
| 16 | Danaher Corporation | $178.08 | 1.1% | $126.04B | 35.3 | 0.4% | 0.7% | Healthcare | -7.3% | 4% | ||
| 17 | CVS Health Corporation | $91.37 | 2.1% | $116.58B | 65.7 | -45.8% | 2.9% | Healthcare | 43.7% | 7.6% | ||
| 18 | Stryker Corporation | $295.00 | 0.6% | $112.98B | 35.1 | 8.2% | 1.1% | Healthcare | -22.6% | 11.2% | ||
| 19 | Bristol-Myers Squibb Company | $54.72 | 0.5% | $111.72B | 15.9 | 33.6% | 4.5% | Healthcare | 13.8% | 1.8% | ||
| 20 | Vertex Pharmaceuticals Incorporated | $428.41 | 0.8% | $108.97B | 28.0 | 530.1% | — | Healthcare | -4% | 10.4% | ||
| 21 | Sanofi | $42.37 | -1% | $102.33B | 18.0 | 96.2% | 5.1% | Healthcare | -13.9% | 14.1% | ||
| 22 | Medtronic plc | $77.95 | 5.7% | $100.08B | 21.6 | 9.1% | 3.6% | Healthcare | -8.9% | 6.9% | ||
| 23 | GSK plc | $49.72 | 1.5% | $99.99B | 6.6 | 120.3% | 6.6% | Healthcare | 22.9% | 5.4% | ||
| 24 | McKesson Corporation | $739.53 | 0.4% | $88.89B | 19.3 | 49.1% | 0.4% | Healthcare | 3.4% | 12.4% | ||
| 25 | Elevance Health Inc. | $391.27 | 0.6% | $84.97B | 15.6 | -8.3% | 1.8% | Healthcare | 3.2% | 9.4% | ||
| 26 | HCA Healthcare, Inc. | $363.23 | -1.1% | $81.21B | 12.8 | 29.1% | 0.8% | Healthcare | -5.2% | 7.1% | ||
| 27 | Cigna Corporation | $270.73 | -0.7% | $71.38B | 12.2 | 30.6% | 2.2% | Healthcare | -13.1% | 8.8% | ||
| 28 | Boston Scientific Corporation | $47.69 | 0% | $70.88B | 24.6 | 54.8% | — | Healthcare | -53.7% | 19.9% | ||
| 29 | Regeneron Pharmaceuticals, Inc. | $618.95 | 2.7% | $64.31B | 14.9 | 4.5% | 0.6% | Healthcare | 26.9% | 5.9% | ||
| 30 | Becton, Dickinson and Company | $145.61 | 0.8% | $52.75B | 25.0 | -24.6% | 2.9% | Healthcare | 38.1% | 2.4% | ||
| 31 | Cencora, Inc. | $263.64 | -0.5% | $51.29B | 33.1 | 51.3% | 0.8% | Healthcare | -9.6% | 5.9% | ||
| 32 | argenx SE | $813.14 | 1.4% | $50.32B | 41.4 | 279.7% | — | Healthcare | 41% | 174% | ||
| 33 | Edwards Lifesciences Corporation | $86.00 | -1.9% | $49.58B | 47.0 | -73.7% | — | Healthcare | 10.7% | 11.2% | ||
| 34 | Takeda Pharmaceutical Company Limited | $15.03 | -1% | $46.97B | 37.6 | 80.5% | 4.3% | Healthcare | 0.4% | -0.7% | ||
| 35 | Cardinal Health, Inc. | $195.85 | 0.5% | $46.09B | 30.4 | 2% | 1% | Healthcare | 26% | 12.8% | ||
| 36 | IDEXX Laboratories, Inc. | $560.73 | 1.8% | $44.54B | 42.9 | 25.3% | — | Healthcare | 6.6% | 13.1% | ||
| 37 | Humana Inc. | $327.54 | 2.1% | $39.32B | 33.3 | -33.9% | 1.1% | Healthcare | 40.3% | 14.1% | ||
| 38 | Alnylam Pharmaceuticals, Inc. | $292.70 | 2.3% | $39.05B | 125.6 | 301.4% | — | Healthcare | -3.6% | 82.6% | ||
| 39 | Haleon plc | $8.72 | 0.2% | $38.83B | 18.0 | 53.3% | 2% | Healthcare | -21.1% | 10.7% | ||
| 40 | Agilent Technologies, Inc. | $137.40 | 1.7% | $38.83B | 30.1 | 23% | 0.7% | Healthcare | 21.9% | 9.1% | ||